CD4 and metabolic dysfunction-associated steatotic liver disease: Notably, chronic systemic inflammation caused by abnormal levels of CD4+T cells and NK cells in PsA patients promotes the occurrence and development of hepatic steatosis, especially NAFLD, and significantly increases the risk of advanced liver disease.